When everything is green and we are red, despite having Phase II right around the corner, it is difficult to stay in here day in and day out. To me, the market makers know that over time they can wear out most investors until they can't stand seeing red anymore. I think we are going to see this stock price move up like no stock has done in recent memory. The fact that we are having so many red days despite what is obvious here, clearly tells me that the news is going to be good. The MM's want us to believe that since we are always red, that there is some "built in" bad news that someone already knows about. This cat and mouse game with the MM's is NOT for the faint of heart let me tell you. Peace.
The moment of truth is nearly upon us!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! We could see 100-300% gains over several trading days once the statistically significant results are announced to the world!!
NBS10 is designed to address a significant medical need for which there is currently no effective treatment, potentially improving longevity and quality of life for those suffering a STEMI, and positioning NeoStem to capture a meaningful share of this worldwide market
NeoStem anticipates release of data from the PreSERVE AMI Phase 2 clinical trial on November 17, 2014 at the American Heart Association's Scientific Sessions, or sooner if results are available.
We know it is never easy making money in the stock market. You have to have discipline to win at this game. Discipline to stick with your beliefs and the company's fundamentals. Still excellent.
Yep. This is how they do it. If you believe in AMR-001, then there is nothing to worry about. If you don't believe in it, get out now.
Let's face it jca. The reality is, if AMR-001 fails, then you can light the rest of the NBS pipeline on fire as far as I am concerned. EVERYTHING for the foreseeable future of the stock hinges on AMR-001 success/failure(IMO).
Well articulated g.best............. In reference to your below comment(isn't that a company to hold for the long term?), I think we both see how big this therapy could be for post heart attack patients. This therapy is unique and cannot be replicated. What better therapy than to use one's own cells to heal one's own heart????????? Game changer and we will be rewarded for identifying such a game changer stock soon enough.
You have to have guts to invest in clinical stage biotech. All it takes is 1-2 days of 100-300% gains to make us all rich........Can't wait til the 17th!!
All the trading on this stock has been on VERY LOW volume........When we see heavy buying or selling for at least several days in a row, it will tell us the true strength of the stock.
We have the catalyst. If you are already in the stock, you don't have to wait too long to get the answers we need here. If the news is bad, the price of the stock already reflects that. IF the news is good, we will double or triple instantly. A VERY good risk/reward scenario if you ask me.
No worries. The science behind it is proven. Nov 17th is a mere formality.
If the primary endpoin should not be met, does the stock ank or do u think that it is already baked into the current prce? I say it is.